Gene Query: VHL

Dataset Description Geneva Score
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 42.18
RIG-I and MDA5 fRIP during KSHV lytic reactivation 38.08
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 28.28
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 26.99
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 22.38
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 21.35
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 21.34
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 21.17
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 19.97
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 19.97
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 19.3
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 19.3
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 18.4
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 16.92
Mitochondrial dsRNA triggers antiviral signalling in humans 16.92
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 16.47
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 16.47
In situ CAPTURE of chromatin interactions by biotinylated dCas9 15.98
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 15.98
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 15.76
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 15.6
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 15.6
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 15.3
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 15.3
Biological effect of chronic mistranslation in mammalian cells 15.27
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 15.08
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 14.89
Altering cancer transcriptomes using epigenomic inhibitors 14.89
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 14.54
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 13.55
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 13.16
TT-Seq captures the human transient transcriptome 12.84
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 12.7
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 12.55
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 12.55
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 12.43
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 12.27
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 12.27
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 12.19
Genome wide expression change by RNF168 knocking down in MCF-7 cells 12.18
LncRNA-GAS5 negative regulation of YAP-target genes expression 11.8
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 11.68
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 11.39
Systematic discovery of endogenous human ribonucleoprotein complexes 11.33
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 11.28
Control of prostate tumour growth by the long non-coding RNA GHSROS 11.05
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 10.85
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 10.78
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 10.78
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 10.76
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 10.76
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 10.76
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 10.54
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 10.43
SLAM-seq for K562 endogenous mRNA decay 10.39
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 10.36
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 10.32
MYC dependent mRNA translation shapes gene expression and cell biology 10.28
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 10.2
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 10.15
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 9.85
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 9.84
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 9.77
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 9.77
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 9.75
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 9.74
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 9.7
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 9.7
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 9.63
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 9.59
RNAseq Analysis in glioblastoma cells treated with Mepazine 9.5
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 9.48
RNA sequencing of GlyH-101-treated MCF-7 cell line 9.46
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 9.42
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 9.38
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 9.24
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 9.22
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 9.22
Integrating single-cell transcriptomic data across different conditions, technologies, and species 9.13
Zika infected neural stem cells 9.11
Transcriptome analysis of Zika infected neural stem cells 9.11
K562 polyA RNA-Seq 9.1
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 9.06
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 9.06
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 9.0
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 8.8
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 8.79
Differential analysis of gene regulation at transcript resolution by RNA-Seq 8.79
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 8.67
Lipid degradation promotes prostate cancer cell survival 8.66
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 8.65
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 8.65
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 8.64
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 8.6
3’ Uridylation Expands miRNA Target Repertoire 8.54
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 8.52
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 8.51
RNA-seq of YB5 cells treated with Proscillaridin A 8.5
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 8.43
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 8.41
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 8.4
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 8.2
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 8.13
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 8.09
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 8.09
Interaction between mitoNEET and NAF-1 in cancer cells 8.06
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 8.06
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 8.0
Silencing SPIB in attached and floating state of H1703 lung cancer cells 7.96
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 7.95
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 7.89
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 7.87
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 7.86
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 7.86
U1 snRNP telescripting regulates size-function stratified human genome 7.83
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 7.83
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 7.83
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 7.79
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 7.79
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 7.78
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 7.74
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 7.73
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 7.7
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 7.7
Paxillin regulates genomic networks in prostate cancer [LNCaP] 7.68
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 7.66
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 7.57
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 7.53
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 7.52
The transcriptome effect of overexpressing EZH2 in MCF7 7.51
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 7.45
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 7.43
Effect of PRDM11 depletion in U2932 cells 7.33
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 7.33
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 7.3
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 7.18
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 7.12
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 7.05
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 7.04
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 7.04
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 7.04
Overexpression of NFIB and YBX1 in MCF-7 cells 7.0
The evolution of N6-methyladenosine in primates 6.97
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 6.91
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 6.81
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 6.79
Cleavage Factor Im as a key regulator of 3’ UTR length 6.73
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 6.63
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 6.53
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 6.53
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 6.5
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 6.48
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 6.42
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 6.37
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 6.35
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 6.31
Effect of PBK knockdown on C4-2 cell transcriptome 6.26
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 6.25
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 6.19
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 6.17
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 6.17
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 6.15
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 6.15
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 6.15
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 6.1
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 6.06
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 6.06
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 6.04
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 6.03
JunB control of keratinocyte-mediated inflammation [RNA-seq] 6.02
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 6.02
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 6.01
Effect of CHKA knockdown on C4-2 cell transcriptome 6.0
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 6.0
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 5.97
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 5.97
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 5.93
Patient-derived luminal breast cancer xenografts with progestins 5.93
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 5.93
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 5.9
TCF7L1 knockdown in pancreatic cancer 5.89
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 5.86
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 5.86
HNF1 regulates critical functions of the human epididymis epithelium. 5.86
Solid phase chemistry to covalently and reversibly capture thiolated RNA 5.85
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 5.85
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 5.82
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 5.82
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 5.8
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 5.8
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 5.79
Role of XRN2 ribonucleolytic activity in RNA metabolism 5.79
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 5.76
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 5.68
The pause-initiation limit restricts transcription activation in human cells 5.68
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 5.63
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 5.58
Chromatin-informed inference of transcriptional programs in gynecologic cancers 5.58
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 5.58
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 5.55
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 5.55
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 5.54
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 5.53
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 5.52
A transcriptome-wide divergence in protein translation scales with LIN28B expression 5.52
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 5.5
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 5.5
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 5.5
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 5.47
Loss of CREBBP results in gene expression repression in lymphoma cells 5.46
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 5.46
NHLRC1 re-expression in cancer cells 5.45
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 5.44
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 5.44
IDH3a KO RNA-seq 5.38
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 5.37
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 5.37
DART-seq: an antibody-free method for global m6A detection 5.37
MYCL and EP400 are required for Max and MCPyV mediated gene activation 5.32
Cell responses to dysregulated VZV-induced cell-cell fusion 5.31
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 5.3
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 5.29
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.26
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.26
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 5.25
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 5.25
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 5.25
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 5.21
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 5.19
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 5.19
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 5.16
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 5.12
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 5.1
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 5.09
IRF2 is a master regulator of human keratinocyte stem cell fate 5.09
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 5.06
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 5.05
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 5.03
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 4.97
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 4.96
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 4.96
Tracing Enhancer Networks using Epigenetic Traits (TENET) 4.96
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 4.92
RNA-seq in transgenic cells 4.89
Profiling of escape kinetics of viruses subjected to RNAi 4.86
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 4.86
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 4.86
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 4.86
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 4.85
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 4.83
Mutational landscape of splicing genes and functional consequences across 33 cancer types 4.8
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 4.78
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 4.74
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 4.73
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 4.7
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 4.64
RNA-sequencing in immortalized human mammary epithelial cells 4.64
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 4.59
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 4.59
Active translatome profiling with RiboLace in MCF7 cells 4.57
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 4.55
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 4.53
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 4.51
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 4.48
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 4.48
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 4.46
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 4.45
RNA sequencing with KSHV infection and enrichment for circular RNAs 4.45
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 4.45
Differentiation enhances Zika virus infection in neuronal brain cells 4.4
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 4.39
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 4.39
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 4.39
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 4.37
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 4.35
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 4.35
Transcriptomic analysis of the HOTAIR-regulated genes 4.35
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 4.32
Paxillin regulates genomic networks in prostate cancer [PC3] 4.32
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 4.31
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 4.29
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 4.22
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 4.21
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 4.18
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 4.16
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 4.14
RNA-seq of RKO cells with cTAZ KO or putback 4.13
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 4.12
Targeting MTHFD2 in Acute Myeloid Leukemia 4.11
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 4.1
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 4.09
METTL3 and WTAP 4.08
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 4.05
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 4.0
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 3.98
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 3.94
Gene expression in GBM with Cav3.2 inhibition 3.87
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 3.85
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 3.68
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 3.68
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 3.65
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 3.61
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 3.61
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 3.61
nELAVL HITS-CLIP in Alzheimer's Disease patients 3.55
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 3.55
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 3.53
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.52
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 3.51
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 3.43
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 3.43
Global epigenomic reconfiguration during mammalian brain development 3.3
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 3.3
Genome-wide analysis of the Integrator complex (HTS) 3.24
Genome-wide analysis of the Integrator complex 3.24
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.23
Human cell line and subcutaneous tumor 3.21
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 3.18
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 3.16
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.15
Real-time observation of light-controlled transcription in living cells 3.14
Tpl-2 small molecule project 3.11
Tpl-2 and MEK small molecule inhibitors 3.11
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 3.07
Transcriptome analysis upon C6orf203 silencing 3.05
Searching for target genes of miR-508/509/506/514 in HCT116 cells 3.05
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 3.02
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 3.0
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 2.99
ARID1A and ARID1B loss in HCT116 cells 2.98
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.93
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 2.91
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 2.86
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 2.85
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 2.85
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 2.83
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 2.78
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 2.74
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 2.73
Genome-wide discovery of human splicing branchpoints [RNAse] 2.69
Mapping interactions for the TNIP2 hub protein 2.66
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.65
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 2.63
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 2.63
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 2.58
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 2.58
Primate transcript and protein expression levels evolve under compensatory selection pressures 2.58
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 2.55
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.55
Identification of renal resident macrophages across species [C1] 2.55
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 2.54
Transcriptomic analyssis following EHMT1/2 inhibition 2.52
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 2.44
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 2.44
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 2.41
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 2.38
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 2.38
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  2.33
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.32
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 2.31
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 2.3
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 2.3
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 2.3
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 2.28
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 2.27
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 2.21
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.21
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 2.19
Transcriptome-wide modulation of splicing by the exon junction complex 2.19
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 2.17
Gene expression regulated by CSA and CSB in neuroblastoma cell line 2.16
MARS Seq data from human cortical organoids 2.14
Defective structural RNA processing in relapsing-remitting multiple sclerosis 2.12
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 2.11
6mer seed toxicity in tumour suppressive microRNAs 2.09
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.05
RNA-seq analysis upon ARID1B overexpression 2.05
A20 regulates canonical wnt-signaling through an interaction with RIPK4 2.04
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 2.04
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 2.03
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 2.01
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 2.01
Identification of a LIF-responsive replication-competent human β cell 1.99
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.98
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 1.96
Transcriptomic analysis of ERR alpha orphan nuclear receptor 1.95
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 1.94
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 1.93
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.85
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 1.82
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 1.79
Genome-wide discovery of human splicing branchpoints 1.74
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 1.71
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.7
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 1.66
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 1.65
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 1.63
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 1.63
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 1.61
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.61
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 1.59
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 1.58
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 1.58
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 1.57
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.57
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.57
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 1.55
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 1.54
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 1.53
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 1.53
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 1.51
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.51
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 1.47
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 1.47
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.44
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.44
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 1.4
HEK293 TFAM Knockout Expression Study 1.37
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 1.35
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 1.35
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 1.34
Identification of global XBP1s target gene expression in human prostate cancer cells 1.28
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 1.26
Identification of renal resident macrophages across species 1.18
The circadian transcriptional landscape in primary human mammary epithelial cells 1.14
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.06
Activity-dependent transcriptional changes in human neurons 1.01
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.01
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.01
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.99
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.99
Transcriptome sequencing of K-562 cells 0.96
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.96
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.96
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.93
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.93
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.92
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.92
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.92
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 0.91
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.9
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.87
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 0.87
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.82
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 0.82
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.77
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.76
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.76
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.74
mRNA sequencing of oropharyngeal cancer cell lines 0.73
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.67
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 0.64
O-glcnAc reprograms cellular energetics 0.6
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.59
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 0.54
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.51
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.5
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.5
Role of cervicovaginal microbiota in genital inflammation 0.45
Human T-cell lymphoblastic lymphoma samples and control thymuses 0.44
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 0.44
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 0.4
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 0.4
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 0.39
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.3
EGR1-controlled transcriptome of T HESCs 0.29
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.28
Function and hormonal regulation of GATA3 in human first trimester placentation 0.27
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.27
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.27
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.27
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.24
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.24
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.23
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.23
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.22
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 0.22
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.21
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.2
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.2
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 0.17
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.14
Metastasis in triple-negative breast cancer 0.14
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.13
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.11
p53 activity results in DNA replication fork processivity 0.11
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.1
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.09
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 0.08
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 0.08
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.07
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 0.07
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.06
Ribosomal protein RPL26 is the principal target of UFMylation 0.06
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.04
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 0.02
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.02
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.01
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01
mRNA recovered upon RNF219 IP. [RNA-IP] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation